Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA approves IND application for MT-3724

Sep. 9, 2014

Cirmtuzumab begins phase I testing for chronic lymphocytic leukemia

Sep. 9, 2014

FDA removes partial clinical hold on ipafricept

Sep. 8, 2014

FDA awards pembrolizumab accelerated approval for melanoma

Sep. 5, 2014

XBiotech reports phase III data for Xilonix in colorectal cancer

Sep. 4, 2014

Opdivo launched in Japan for unresectable melanoma

Sep. 3, 2014

FDA removes partial clinical hold on vantictumab trials

Sep. 1, 2014

AstraZeneca's MEDI-4736 to be studied in immunological subsets of advanced colorectal cancer

Aug. 29, 2014

OncoPep completes financing round to support development of MM vaccine

Aug. 29, 2014

Lilly to initiate clinical study of cancer candidate LY-3164530

Aug. 29, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026